GLP-1s are known to have positive cardiovascular effects, and better control of blood glucose levels through GLP-1 treatment has been shown to limit small blood vessel damage that can lead to health complications such as diabetic retinopathy
The cell's capacity to synthesise glutathione is described in the literature as determined not by any single amino acid in isolation but by the simultaneous availability of all three, in the right proportions, in the right cellular compartments, in the right metabolic state
CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome
Most GLP-1 side effects related to acute dosing changes happen within 48 hours of the increase
As mentioned earlier, pharmacological use of GLP-1 agonists is primarily taken to treat T2D and obesity, and they have impactful effects to achieve in desired results to regulate plasma glucose levels, they also reduce hunger and suppress daily calorie intake